Dr. Andrew Miki is the founder and Chief Science Officer of Starling. Andrew founded Starling with the mission to improve access to effective mental healthcare. Andrew leads Starling’s research, strategy, and solutions to address mental health requirements and create validation frameworks to measure and report each digital program’s efficacy. With a background in Clinical Psychology and Neuroscience, Andrew has expertise in neuropsychological assessments and the treatment of Anxiety Disorders, Mood Disorders, and Traumatic Brain Injuries. He continues to practice as a registered psychologist and provides Cognitive Behavioral Therapy for individuals with depression, anxiety, stress, and trauma to help them feel stronger, more confident and resilient. Andrew holds a BSc in Psychology from Queen’s University, an MA in Behavioral Neuroscience from Wilfrid Laurier and an MA and PhD in Clinical Psychology from York University.